The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC).
The European Centre for Disease Prevention and Control (ECDC) has published a report today highlighting the threat of increasing antimicrobial resistance (AMR) in Neisseria gonorrhoeae.
In July 2022, the European Commission adopted the proposal for a Regulation on standards of quality and safety for substances of human origin (SoHO) intended for human application.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
The ECDC updates are based on available data reported through the European Surveillance System (TESSy) by the national public health authorities of EU/EEA countries.